UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

The Paddington International Virtual Chromoendoscopy Score in ulcerative colitis exhibits very good inter-rater agreement after computerized module training: a multicenter study across academic and community practice (with video)

Gastrointestinal endoscopy, 2018-07, Vol.88 (1), p.95-106.e2

2018

Volltextzugriff (PDF)

Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis

EBioMedicine, 2022-07, Vol.81, p.104088-104088, Article 104088

2022

Volltextzugriff (PDF)

The analysis of gut microbiota in patients with bile acid diarrhoea treated with colesevelam

Frontiers in microbiology, 2023-03, Vol.14, p.1134105-1134105

2023

Volltextzugriff (PDF)

Integration of stool microbiota, proteome and amino acid profiles to discriminate patients with adenomas and colorectal cancer

Gut microbes, 2022-12, Vol.14 (1), p.2139979-2139979

2022

Volltextzugriff (PDF)

Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-Analysis

Journal of Crohn's and colitis, 2021-07, Vol.15 (7), p.1184-1196

2021

Volltextzugriff (PDF)

Predicting the current and future prevalence of primary sclerosing cholangitis with inflammatory bowel disease (PSC-IBD): a nationwide population-based study

Journal of hepatology, 2023-06, Vol.78, p.S368-S369

2023

Volltextzugriff (PDF)

WED-251 - Predicting the current and future prevalence of primary sclerosing cholangitis with inflammatory bowel disease (PSC-IBD): a nationwide population-based study

Journal of hepatology, 2023-06, Vol.78, p.S368-S369

2023

Volltextzugriff (PDF)

LBP-36 - Oral vancomycin induces remission in PSC-IBD, which is associated with a reduction in bile salt hydrolase and colonic amine oxidase activity

Journal of hepatology, 2023-06, Vol.78, p.S123-S124

2023

Volltextzugriff (PDF)

Oral vancomycin induces remission in PSC-IBD, which is associated with a reduction in bile salt hydrolase and colonic amine oxidase activity

Journal of hepatology, 2023-06, Vol.78, p.S123-S124

2023

Volltextzugriff (PDF)

P694 Age is a strong of predictive risk factor for anti-TNF therapy related adverse events in IBD patients

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1314-i1315

2024

Volltextzugriff (PDF)

Emerging drugs for the treatment of primary sclerosing cholangitis

Current opinion in pharmacology, 2022-02, Vol.62, p.23-35

2022

Volltextzugriff (PDF)

P756 Cumulative adverse events of anti-TNF therapy in IBD patients at a large tertiary centre – a 13-year real-world experience

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i888-i888

2023

Volltextzugriff (PDF)

MYOD-1 in normal colonic mucosa--role as a putative biomarker?

BMC research notes, 2012-07, Vol.5 (1), p.240-240, Article 240

2012

Volltextzugriff (PDF)

Sa1887 IS DIVERSITY IMPORTANT IN THE GUT MICROBIOME AT IBD ONSET? A SYSTEMATIC REVIEW OF THE LITERATURE AND META-ANALYSIS OF ALPHA-DIVERSITY DATA

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-565-S-566

2024

Volltextzugriff (PDF)

Sa1883 INCREASED ABUNDANCE AND ACTIVITY OF SUTTERELLA WADSWORTHENSIS AT DISEASE ONSET, ALONGSIDE DEPLETION OF SHORT CHAIN FATTY ACID PRODUCING CLOSTRIDIALES, ASSOCIATES WITH INCREASED USE OF ADVANCED THERAPIES IN THE FIRST TWO YEARS OF IBD DIAGNOSIS

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-564-S-564

2024

Volltextzugriff (PDF)

Mucosal immunity in primary sclerosing cholangitis: from the bowel to bile ducts and back again

Current opinion in gastroenterology, 2022-03, Vol.38 (2), p.104

2022

Volltextzugriff (PDF)

A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways

Journal of Crohn's and colitis, 2020-07, Vol.14 (7), p.935-947

2020

Volltextzugriff (PDF)

Tu1254 Syringe Size Influences the Amount of Benzodiazepine Administered During Sedated Endoscopy

Gastrointestinal endoscopy, 2013-05, Vol.77 (5), p.AB475-AB475

2013

Volltextzugriff (PDF)

Precision Medicine with FMT for Ulcerative Colitis: Are We There Yet?

Journal of Crohn's and colitis, 2021-04, Vol.15 (4), p.519-520

2021

Volltextzugriff (PDF)

Su1994 ORAL IRON THERAPY PROMOTES A PROINFLAMMATORY GUT MICROBIOTA IN COLORECTAL CANCER PATIENTS WITH IRON DEFICIENCY ANAEMIA

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-737-S-738

2020

Volltextzugriff (PDF)

Su1995 MICROBIOLOGICAL AND IMMUNOLOGICAL INFLAMMATORY IMMUNE RESPONSES IN ANAEMIC COLORECTAL CANCER PATIENTS TREATED WITH ORAL IRON THERAPY

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-738-S-738

2020

Volltextzugriff (PDF)

Faecal Microbiota Transplantation [FMT] in the Treatment of Chronic Refractory Pouchitis: A Systematic Review and Meta-analysis

Journal of Crohn's and colitis, 2024-01, Vol.18 (1), p.144-161

2024

Volltextzugriff (PDF)

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

The Journal of hospital infection, 2018-09, Vol.100, p.S1-S31

2018

Volltextzugriff (PDF)

Tu1969 Predictors of Post-Operative Recurrence of Ileal Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S993-S993

2016

Volltextzugriff (PDF)

Mo1220 Faecal Microbiota Transplantation via Nasogastric Route for the Treatment of Recurrent and Antibiotic Refractory Clostridum difficile Infection: The UK Experience

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-641-S-642

2015

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Paddington International Virtual Chromoendoscopy Score in ulcerative colitis exhibits very good inter-rater agreement after computerized module training: a multicenter study across academic and community practice (with video)

Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis

The analysis of gut microbiota in patients with bile acid diarrhoea treated with colesevelam

Integration of stool microbiota, proteome and amino acid profiles to discriminate patients with adenomas and colorectal cancer

Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-Analysis

Predicting the current and future prevalence of primary sclerosing cholangitis with inflammatory bowel disease (PSC-IBD): a nationwide population-based study

WED-251 - Predicting the current and future prevalence of primary sclerosing cholangitis with inflammatory bowel disease (PSC-IBD): a nationwide population-based study

LBP-36 - Oral vancomycin induces remission in PSC-IBD, which is associated with a reduction in bile salt hydrolase and colonic amine oxidase activity

Oral vancomycin induces remission in PSC-IBD, which is associated with a reduction in bile salt hydrolase and colonic amine oxidase activity

P694 Age is a strong of predictive risk factor for anti-TNF therapy related adverse events in IBD patients

Emerging drugs for the treatment of primary sclerosing cholangitis

P756 Cumulative adverse events of anti-TNF therapy in IBD patients at a large tertiary centre – a 13-year real-world experience

MYOD-1 in normal colonic mucosa--role as a putative biomarker?

Sa1887 IS DIVERSITY IMPORTANT IN THE GUT MICROBIOME AT IBD ONSET? A SYSTEMATIC REVIEW OF THE LITERATURE AND META-ANALYSIS OF ALPHA-DIVERSITY DATA

Sa1883 INCREASED ABUNDANCE AND ACTIVITY OF SUTTERELLA WADSWORTHENSIS AT DISEASE ONSET, ALONGSIDE DEPLETION OF SHORT CHAIN FATTY ACID PRODUCING CLOSTRIDIALES, ASSOCIATES WITH INCREASED USE OF ADVANCED THERAPIES IN THE FIRST TWO YEARS OF IBD DIAGNOSIS

Mucosal immunity in primary sclerosing cholangitis: from the bowel to bile ducts and back again

A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways

Tu1254 Syringe Size Influences the Amount of Benzodiazepine Administered During Sedated Endoscopy

Precision Medicine with FMT for Ulcerative Colitis: Are We There Yet?

Su1994 ORAL IRON THERAPY PROMOTES A PROINFLAMMATORY GUT MICROBIOTA IN COLORECTAL CANCER PATIENTS WITH IRON DEFICIENCY ANAEMIA

Su1995 MICROBIOLOGICAL AND IMMUNOLOGICAL INFLAMMATORY IMMUNE RESPONSES IN ANAEMIC COLORECTAL CANCER PATIENTS TREATED WITH ORAL IRON THERAPY

Faecal Microbiota Transplantation [FMT] in the Treatment of Chronic Refractory Pouchitis: A Systematic Review and Meta-analysis

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Tu1969 Predictors of Post-Operative Recurrence of Ileal Crohn's Disease

Mo1220 Faecal Microbiota Transplantation via Nasogastric Route for the Treatment of Recurrent and Antibiotic Refractory Clostridum difficile Infection: The UK Experience

Aktive Filter

Suchergebnisse filtern